{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35718800", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10305", "10.1038/s41598-022-13599-y"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "12", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "19"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "In vitro study on efficacy of PHELA, an African traditional drug against SARS-CoV-2.", "Pagination": {"StartPage": "10305", "MedlinePgn": "10305"}, "Abstract": {"AbstractText": ["In 2019, coronavirus has made the third apparition in the form of SARS-CoV-2, a novel strain of coronavirus that is extremely pathogenic and it uses the same receptor as SARS-CoV, the angiotensin-converting enzyme 2 (ACE2). However, more than 182 vaccine candidates have been announced; and 12 vaccines have been approved for use, although, even vaccinated individuals are still vulnerable to infection. In this study, we investigated PHELA, recognized as an herbal combination of four exotic African medicinal plants namely; Clerodendrum glabrum E. Mey. Lamiaceae, Gladiolus dalenii van Geel, Rotheca myricoides (Hochst.) Steane & Mabb, and Senna occidentalis (L.) Link; as a candidate therapy for COVID-19. In vitro testing found that PHELA inhibited\u2009>\u200990% of SARS-CoV-2 and SARS-CoV infection at concentration levels of 0.005\u00a0mg/ml to 0.03\u00a0mg/ml and close to 100% of MERS-CoV infection at 0.1\u00a0mg/ml to 0.6\u00a0mg/ml. The in vitro average IC<sub>50</sub> of PHELA on SARS-COV-2, SARS-CoV and MERS-COV were\u2009~\u20090.01\u00a0mg/ml. Secondly in silico docking studies of compounds identified in PHELA showed very strong binding energy interactions with the SARS-COV-2 proteins. Compound 5 showed the highest affinity for SARS-COV-2 protein compared to other compounds with the binding energy of -\u00a06.8\u00a0kcal\u00a0mol<sup>-1</sup>. Our data showed that PHELA has potential and could be developed as a COVID-19 therapeutic."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, 9300, South Africa. MatsabisaMG@ufs.ac.za."}], "LastName": "Matsabisa", "ForeName": "M G", "Initials": "MG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Synthetic Biology Centre, Next Generation Health Cluster, Council for Scientific and Industrial Research, Pretoria, Gauteng, South Africa. AAlexandre@csir.co.za."}], "LastName": "Alexandre", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pure and Industrial Chemistry, Faculty of Physical Sciences, University of Nigeria, Nsukka, 410001, Nigeria."}], "LastName": "Ibeji", "ForeName": "Collins U", "Initials": "CU"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, 9300, South Africa."}], "LastName": "Tripathy", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, 9300, South Africa."}], "LastName": "Erukainure", "ForeName": "Ochuko L", "Initials": "OL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Synthetic Biology Centre, Next Generation Health Cluster, Council for Scientific and Industrial Research, Pretoria, Gauteng, South Africa."}], "LastName": "Malatji", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Synthetic Biology Centre, Next Generation Health Cluster, Council for Scientific and Industrial Research, Pretoria, Gauteng, South Africa."}], "LastName": "Chauke", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Advanced Agriculture and Food Cluster, Council for Scientific and Industrial Research, Pretoria, South Africa."}], "LastName": "Okole", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Science and Innovation, Indigenous Knowledge-based Technology Innovations, Brummeria, Pretoria, 0001, South Africa."}], "LastName": "Chabalala", "ForeName": "H P", "Initials": "HP"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lamiaceae"}, {"QualifierName": [], "DescriptorName": "Medicine, Traditional"}, {"QualifierName": [], "DescriptorName": "Middle East Respiratory Syndrome Coronavirus"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wu D, et al. The SARS-CoV-2 outbreak: What we know. Int. J. Infect. Dis. 2020;94:44\u201348. doi: 10.1016/j.ijid.2020.03.004.", "ArticleIdList": ["10.1016/j.ijid.2020.03.004", "PMC7102543", "32171952"]}, {"Citation": "Guo YR, Cao QD, Hong ZS, Tan YY, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2014An update on the status. Mil. Med. Res. 2020;7(1):1\u201310.", "ArticleIdList": ["PMC7068984", "32169119"]}, {"Citation": "Sarkar C, et al. Potential therapeutic options for COVID-19, current status, challenges, and future perspectives. Front. Pharmacol. 2020;11:1428. doi: 10.3389/fphar.2020.572870.", "ArticleIdList": ["10.3389/fphar.2020.572870", "PMC7522523", "33041814"]}, {"Citation": "Funk CD, Laferri\u00e8re C, Ardakani A. Target product profile analysis of COVID-19 vaccines in phase III clinical trials and beyond, an early 2021 perspective. Viruses. 2021;13(3):418. doi: 10.3390/v13030418.", "ArticleIdList": ["10.3390/v13030418", "PMC7998902", "33807839"]}, {"Citation": "Koch T, et al. Correlates of vaccine-induced protection against SARS-CoV-2. Vaccines. 2021;9(3):238. doi: 10.3390/vaccines9030238.", "ArticleIdList": ["10.3390/vaccines9030238", "PMC8035658", "33801831"]}, {"Citation": "Sui Y, Bekele Y, Berzofsky JA. Potential SARS-CoV-2 immune correlates of protection in infection and vaccine immunization. Pathogens. 2021;10(2):138. doi: 10.3390/pathogens10020138.", "ArticleIdList": ["10.3390/pathogens10020138", "PMC7912691", "33573221"]}, {"Citation": "Dagotto G, Yu J, Barouch DH. Approaches and challenges in SARS-CoV-2 vaccine development. Cell Host Microbe. 2020;28:364\u2013370. doi: 10.1016/j.chom.2020.08.002.", "ArticleIdList": ["10.1016/j.chom.2020.08.002", "PMC7416703", "32798444"]}, {"Citation": "Sariol A, Perlman S. Lessons for COVID-19 immunity from other coronavirus infections. Immunity. 2020;53:248\u2013263. doi: 10.1016/j.immuni.2020.07.005.", "ArticleIdList": ["10.1016/j.immuni.2020.07.005", "PMC7359787", "32717182"]}, {"Citation": "Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861\u2013880. doi: 10.1016/j.cell.2021.01.007.", "ArticleIdList": ["10.1016/j.cell.2021.01.007", "PMC7803150", "33497610"]}, {"Citation": "Huang AT, et al. A systematic review of antibody mediated immunity to coronaviruses, kinetics, correlates of protection, and association with severity. Nat. Commun. 2020;11(1):1\u201316. doi: 10.1038/s41467-019-13993-7.", "ArticleIdList": ["10.1038/s41467-019-13993-7", "PMC7499300", "32943637"]}, {"Citation": "McMahan K, et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature. 2021;590(7847):630\u2013634. doi: 10.1038/s41586-020-03041-6.", "ArticleIdList": ["10.1038/s41586-020-03041-6", "PMC7906955", "33276369"]}, {"Citation": "Simonovich VA, et al. A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N. Engl. J. Med. 2021;384(7):619\u2013629. doi: 10.1056/NEJMoa2031304.", "ArticleIdList": ["10.1056/NEJMoa2031304", "PMC7722692", "33232588"]}, {"Citation": "Iyer AS, et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci. Immunol. 2020;5(52):eabe0367. doi: 10.1126/sciimmunol.abe0367.", "ArticleIdList": ["10.1126/sciimmunol.abe0367", "PMC7857394", "33033172"]}, {"Citation": "Dan JM, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529):eabf4063. doi: 10.1126/science.abf4063.", "ArticleIdList": ["10.1126/science.abf4063", "PMC7919858", "33408181"]}, {"Citation": "Ward BJ, et al. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nat. Med. 2021;27(6):1071\u20131078. doi: 10.1038/s41591-021-01370-1.", "ArticleIdList": ["10.1038/s41591-021-01370-1", "PMC8205852", "34007070"]}, {"Citation": "Tang F, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome, a six-year follow-up study. J. Immunol. Res. 2011;186(12):7264\u20137268.", "ArticleIdList": ["21576510"]}, {"Citation": "Ng O-W, et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016;34(17):2008\u20132014. doi: 10.1016/j.vaccine.2016.02.063.", "ArticleIdList": ["10.1016/j.vaccine.2016.02.063", "PMC7115611", "26954467"]}, {"Citation": "Hoareau L, DaSilva EJ. Medicinal plants, a re-emerging health aid. Electron. J. Biotechnol. 1999;2(2):3\u20134."}, {"Citation": "Jahan I, Ahmet ONAY. Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk. J. Biol. 2020;44(SI-1):228\u2013241. doi: 10.3906/biy-2005-114.", "ArticleIdList": ["10.3906/biy-2005-114", "PMC7314514", "32595359"]}, {"Citation": "Andrighetti-Fr\u00f6hner CR, et al. Antiviral evaluation of plants from Brazilian atlantic tropical forest. Fitoterapia. 2005;76(3\u20134):374\u2013378. doi: 10.1016/j.fitote.2005.03.010.", "ArticleIdList": ["10.1016/j.fitote.2005.03.010", "15890472"]}, {"Citation": "Alam S, et al. Pharmacological and computer-aided studies provide new insights into Millettia peguensis Ali (Fabaceae) Saudi Pharm. J. 2020;28(12):1777\u20131790. doi: 10.1016/j.jsps.2020.11.004.", "ArticleIdList": ["10.1016/j.jsps.2020.11.004", "PMC7783235", "33424267"]}, {"Citation": "Gakhar A. Anti-viral phyto medicine, a review. J. Pharmacogn. Phytochem. 2021;10(1):2002\u20132004. doi: 10.22271/phyto.2021.v10.i1ab.13645.", "ArticleIdList": ["10.22271/phyto.2021.v10.i1ab.13645"]}, {"Citation": "Yang Y, et al. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2), a review and perspective. Int. J. Biol. Sci. 2020;16(10):1708. doi: 10.7150/ijbs.45538.", "ArticleIdList": ["10.7150/ijbs.45538", "PMC7098036", "32226288"]}, {"Citation": "Emon NU, et al. Antidepressant, anxiolytic, antipyretic, and thrombolytic profiling of methanol extract of the aerial part of Piper nigrum, in vivo, in vitro, and in silico approaches. Food Sci. Nutr. 2021;9(2):833\u2013846. doi: 10.1002/fsn3.2047.", "ArticleIdList": ["10.1002/fsn3.2047", "PMC7866625", "33598167"]}, {"Citation": "Ang L, et al. Herbal medicine and pattern identification for treating COVID-19, a rapid review of guidelines. Integr. Med. Res. 2020;9(2):100407. doi: 10.1016/j.imr.2020.100407.", "ArticleIdList": ["10.1016/j.imr.2020.100407", "PMC7104236", "32289016"]}, {"Citation": "Alam S, et al. Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19, update on clinical trials and mechanism of actions. Front. Pharmacol. 2021;12:1248.", "ArticleIdList": ["PMC8194295", "34122096"]}, {"Citation": "Lekhooa M, et al. Evaluation of traditional medicines II, the use of metabolite peak-kinetics to monitor PHELA in rat plasma. Afr. J. Tradit. Complement. Altern. Med. 2012;9(3S):73\u201380.", "ArticleIdList": ["PMC3746616", "23983357"]}, {"Citation": "Matsabisa et al. Internal Report, Medical Research Council, South Africa. (2006)."}, {"Citation": "Lekhooa M, Walubo A, Du Plessis JJ, Matsabisa MC, Molefe D. Evaluation of traditional medicines I, Identification of Phela using different chromatographic techniques. Afr. J. Tradit. Complement Altern. Med. 2012;9(3S):27\u201339.", "ArticleIdList": ["PMC3746620", "23983353"]}, {"Citation": "Lekhooa MR, et al. The development and use of a drug-induced immunosuppressed rat-model to screen Phela for mechanism of immune stimulation. J. Ethnopharmacol. 2017;206:8\u201318. doi: 10.1016/j.jep.2017.04.031.", "ArticleIdList": ["10.1016/j.jep.2017.04.031", "28473245"]}, {"Citation": "Das B, et al. Anti-cholinesterase potential of standardized extract of PHELA a traditional South African medicine formulation. J. Herb. Med. 2020;22:100348. doi: 10.1016/j.hermed.2020.100348.", "ArticleIdList": ["10.1016/j.hermed.2020.100348"]}, {"Citation": "Wei X, et al. Antibody neutralization and escape by HIV-1. Nature. 2003;422(6929):307\u2013312. doi: 10.1038/nature01470.", "ArticleIdList": ["10.1038/nature01470", "12646921"]}, {"Citation": "Sanner MF. Python, a programming language for software integration and development. J. Mol. Graph Model. 1999;17(1):57\u201361.", "ArticleIdList": ["10660911"]}, {"Citation": "Morris GM, et al. AutoDock4 and AutoDockTools4, Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30(16):2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Frisch, M. J., et al. Entering Gaussian System, Link 0= g09 Initial command,/home/software/g09/l1. exe/tmp/10epi_SRRRR_nmr/10epi_SRRRR_b3631_4_pbe_nmr/Gau-7875. inp-scrdir=/tmp/10epi_SRRRR_nmr/10epi_SRRRR_b3631_4_pbe_nmr/Entering Link 1=/home/software/g09/l1. exe PID= 7876."}, {"Citation": "Trott O, Olson AJ. AutoDock Vina, improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31(2):455\u2013461.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Kannan SR, et al. Infectivity of SARS-CoV-2: There is something more than D614G? J Neuroimmune. Pharmacol. 2020;15(4):574\u2013577. doi: 10.1007/s11481-020-09954-3.", "ArticleIdList": ["10.1007/s11481-020-09954-3", "PMC7490321", "32930936"]}, {"Citation": "Wang H, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:1629\u20131635. doi: 10.1007/s10096-020-03899-4.", "ArticleIdList": ["10.1007/s10096-020-03899-4", "PMC7180649", "32333222"]}, {"Citation": "Li W, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450\u2013454. doi: 10.1038/nature02145.", "ArticleIdList": ["10.1038/nature02145", "PMC7095016", "14647384"]}, {"Citation": "Mobaraki K, Ahmadzadeh J. Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1.2017 to 17.1.2018, a cross-sectional study. BMC Infect. Dis. 2019;19(1):1\u20135. doi: 10.1186/s12879-019-3987-2.", "ArticleIdList": ["10.1186/s12879-019-3987-2", "PMC6487021", "31029095"]}, {"Citation": "Zhang Y-Z, Holmes EC. A genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 2020;181(2):223\u2013227. doi: 10.1016/j.cell.2020.03.035.", "ArticleIdList": ["10.1016/j.cell.2020.03.035", "PMC7194821", "32220310"]}, {"Citation": "Rabablert J, et al. Activity of methanolic andrographis paniculate crude extract and its purified andrographolide against Japanese-encephalitis virus. Sci. Eng. Health Stud. 2021;15:21030007."}, {"Citation": "Zhang H-T, et al. Evaluation of the adjuvant efficacy of natural herbal medicine on COVID-19, a retrospective matched case-control study. Am. J. Chin. Med. 2020;48(04):779\u2013792. doi: 10.1142/S0192415X20500391.", "ArticleIdList": ["10.1142/S0192415X20500391", "32420751"]}, {"Citation": "Bhuiyan FR, et al. Plant\u2019s metabolites, possibility of natural therapeutics against the COVID-19 pandemic. Front. Med. 2020;7:444. doi: 10.3389/fmed.2020.00444.", "ArticleIdList": ["10.3389/fmed.2020.00444", "PMC7427128", "32850918"]}, {"Citation": "Ning L, et al. Development and application of therapeutic antibodies against COVID-19. Int. J. Biol. Sci. 2021;17(6):1486. doi: 10.7150/ijbs.59149.", "ArticleIdList": ["10.7150/ijbs.59149", "PMC8071770", "33907512"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "12"}, {"Year": "2022", "Month": "5", "Day": "9"}, {"Year": "2022", "Month": "6", "Day": "19", "Hour": "23", "Minute": "16"}, {"Year": "2022", "Month": "6", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["35718800", "PMC9207029", "10.1038/s41598-022-13599-y", "10.1038/s41598-022-13599-y"]}}], "PubmedBookArticle": []}